In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a ...

Researchers have developed new CAR-T cells to target malignant tumors. Their method targeted a protein found in high amounts ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

Marcela Maus , MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O'Keeffe Endowed Chair of the Mass ...